Literature DB >> 28043357

Do antimicrobial peptides PR-39, PMAP-36 and PMAP-37 have any effect on bacterial growth and quality of liquid-stored boar semen?

Eva Bussalleu1, Sílvia Sancho2, Maria D Briz2, Marc Yeste2, Sergi Bonet2.   

Abstract

The use of antimicrobial peptides (AMP) has become one of the most promising alternatives to the use of antibiotics (Abs) in semen extender's formulation to overcome the increasing bacterial resistance to antibiotics. However, AMP may impair boar sperm quality, so that their deleterious effects might be higher than their effectiveness against bacteria. Thus, the aim of this study was to determine whether three different AMP, the proline-arginine-rich antimicrobial peptide PR-39 (PR-39), and the porcine myeloid antimicrobial peptides 36 (PMAP-36) and 37 (PMAP-37) had any effect upon boar sperm quality and bacterial growth. For this purpose, three different concentrations of each peptide (1 μM, 10 μM and 20 μM for PR-39 and 0.5 μM, 1 μM and 3 μM for PMAP-36 and PMAP-37) were added to 2 mL of a pool of extended semen with BTS without Abs; two controls, one without AMPs and Abs, and the other with Abs only were used for each peptide (n = 3). Total (TMOT) and progressive (PMOT) sperm motility, sperm viability and bacterial concentration were assessed before the addition of each AMP or Abs and at 1, 3, 6, 8 and 10 days post-addition. For each AMP, results revealed a drop in the TMOT and PMOT in all treatments and controls. In regard to sperm viability, while PR-39 at 10 μM maintained it in values similar to those of the control with Abs and PMAP-36 kept also the sperm viability in a similar fashion to the treatment with Abs, PMAP-37 was more effective in keeping sperm viability than controls (P < 0.05). Whereas PR-39 at 20 μM and PMAP-37 at 3 μM were quite effective in controlling bacterial load, PMAP-36 did not avoid bacterial growth at any concentration tested. In conclusion, taking all results together, PMAP-37 seems to be a suitable candidate to replace Abs in extended semen, as it hardly impairs sperm viability and controls the bacterial load. Nevertheless, further studies are still required to improve its effectiveness.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Antibiotics; Antimicrobial peptides; Artificial insemination; Bacteriospermia; Boar; Semen

Mesh:

Substances:

Year:  2016        PMID: 28043357     DOI: 10.1016/j.theriogenology.2016.11.017

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  6 in total

1.  Does natural honey act as an alternative to antibiotics in the semen extender for cryopreservation of crossbred ram semen?

Authors:  M N Banday; F A Lone; F Rasool; H A Rather; M A Rather
Journal:  Iran J Vet Res       Date:  2017       Impact factor: 1.376

Review 2.  Porcine Myeloid Antimicrobial Peptides: A Review of the Activity and Latest Advances.

Authors:  Shuaibing Shi; Tengfei Shen; Yongqing Liu; Liangliang Chen; Chen Wang; Chengshui Liao
Journal:  Front Vet Sci       Date:  2021-05-14

3.  Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father.

Authors:  Louise C Kenny; Douglas B Kell
Journal:  Front Med (Lausanne)       Date:  2018-01-04

4.  Enhancing the antibacterial activity of antimicrobial peptide PMAP-37(F34-R) by cholesterol modification.

Authors:  Liangliang Chen; Tengfei Shen; Yongqing Liu; Jiangfei Zhou; Shuaibing Shi; Yang Wang; Zhanqin Zhao; Zhiling Yan; Chengshui Liao; Chen Wang
Journal:  BMC Vet Res       Date:  2020-11-02       Impact factor: 2.741

Review 5.  Current and alternative trends in antibacterial agents used in mammalian semen technology.

Authors:  Caio Sérgio Santos; Alexandre Rodrigues Silva
Journal:  Anim Reprod       Date:  2020-03-17       Impact factor: 1.807

6.  Low temperature preservation of porcine semen: influence of short antimicrobial lipopeptides on sperm quality and bacterial load.

Authors:  B Hensel; U Jakop; K Scheinpflug; K Mühldorfer; F Schröter; J Schäfer; K Greber; M Jung; M Schulze
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.